TELEFLEX INCORPORATED

TFX ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2010 FY2009 FY2008
Revenue $1.40B $1.43B $1.91B
Cost of Revenue $718.9M $749.3M $1.11B
Gross Profit $678.8M $685.5M $801.5M
Gross Margin 48.6% 47.8% 41.9%
Operating Expenses
Research & Development $42.4M $36.7M $32.6M
SG&A Expense $403.6M $388.3M $502.6M
Operating Income $230.3M $250.2M $239.0M
Operating Margin 16.5% 17.4% 12.5%
Interest Expense $79.8M $89.1M $121.6M
Pretax Income $104.6M $163.6M $119.6M
Income Tax Expense $16.9M $37.0M $37.9M
Net Income $201.1M $303.0M $119.8M
Net Margin 14.4% 21.1% 6.3%
EPS (Basic) $5.04 $7.63 $3.03
EPS (Diluted) $4.99 $7.59 $3.01
Shares Outstanding (Basic) 39.9M 39.7M 39.6M
Shares Outstanding (Diluted) 40.3M 39.9M 39.8M
Dividends Per Share $1.36 $1.36 $1.34
← Newer Page 3 of 3 Older →